Systemic inflammatory biomarkers for predicting clinical deterioration in traumatic brain injury
Neurology Asia · 2026-03 · 31 (1) · 305-312
DOI: 10.54029/2026fzc ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurology Asia, 2026-03. Verfasst von Sümeyye Erdaş und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Traumatic brain injury (TBI) is a major cause of morbidity and mortality worldwide. Identifying patients at risk of early clinical deterioration is essential for timely intervention.
Methods
We retrospectively analyzed adult patients with mild to moderate TBI admitted to a tertiary care center. Three biomarkers were calculated from admission labs: red cell distribution width-to-platelet ratio (RPR), C-reactive protein-to-albumin ratio (CAR), and neutrophil-to-lymphocyte ratio × RPR (NLTRP). The primary outcome was deterioration within 5 days, defined as a ≥2-point decline in Glasgow Coma Scale or need for mechanical ventilation. The secondary outcome was 28-day mortality.
Results
Of 378 patients, 67 (17.7%) deteriorated and 30 (10.3%) died within 28 days. RPR (AUC 0.614, p=0.003) and CAR (AUC 0.609, p=0.005) predicted early deterioration. RPR (AUC 0.719, p
Zitieren
APA
Erdaş, S., Ateş, S., Kocaşaban, D. Ü., Tunçel, C. U., & Okumuş, M. (2026). Systemic inflammatory biomarkers for predicting clinical deterioration in traumatic brain injury. Neurology Asia, 31(1), 305-312. https://doi.org/10.54029/2026fzc
Vancouver
Erdaş S, Ateş S, Kocaşaban DÜ, Tunçel CU, Okumuş M. Systemic inflammatory biomarkers for predicting clinical deterioration in traumatic brain injury. Neurology Asia. 2026;31(1):305-312. doi:10.54029/2026fzc
BibTeX
@article{Erda2026,
author = {Erdaş, Sümeyye and Ateş, Serdal and Kocaşaban, Dilber Üçöz and Tunçel, Cansu Uludağ and Okumuş, Mehmet},
title = {Systemic inflammatory biomarkers for predicting clinical deterioration in traumatic brain injury},
journal = {Neurology Asia},
year = {2026},
volume = {31},
number = {1},
pages = {305--312},
doi = {10.54029/2026fzc}
}
EUVIMED